Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats.

Verona Pharma, a year after receiving regulatory approval for its landmark chronic obstructive pulmonary disease (COPD) treatment, is being acquired by pharmaceutical giant Merck in a deal worth about ...

The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., ... (Reuters) -Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, ...

For the third time in four years, CNBC has ranked North Carolina as “America’s Top State for Business” in 2025.

Merck posted Q1 adjusted EPS of $2.22 and revenue of $15.53 billion, ... Merck opened a new $1 billion, 225,000-square-foot vaccine manufacturing facility at its site in Durham, North Carolina.

One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an ...

Seven weeks after opening a new $1 billion vaccine manufacturing facility in North Carolina, Merck has revealed that it is breaking ground on another $1 billion plant—this one in Wilmington ...

Merck said last week its biggest tariff exposure is through Keytruda and it has enough US inventory for this year. It estimated $200 million in additional costs for the levies implemented to date.

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats.